Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + simvastatin versus pravastatin in mixed dyslipidemia inadequately controlled on pravastatin
2006-000515-15Phase 3Completed
- Sponsor
- Fournier Laboratories Ireland
- Start
- Aug 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of fenofibrate, simvastatin and pravastatin in combined dyslipidaemia (3 arms), sponsored by Fournier Laboratories Ireland. Primary endpoints: Percent change in LDL cholesterol, Percent change in triglycerides and 1 more. Started Aug 2006; status: completed.
02
Drugs
fenofibratesimvastatinpravastatin
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on 2006-000515-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000515-15.